Dr. Meredith A. Spindler, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- New York University School of Medicine (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 579
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: New York University School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
PA license MD440276
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hospital of Univ of Pennsylvania Philadelphia, PA
- Christiana Hospital Newark, DE
- Chester County Hospital West Chester, PA
- Pennsylvania Hospital Philadelphia, PA
- Doylestown Hospital Doylestown, PA
Medical groups
- University of Penn - Medical Group (3,505 clinicians)
- Phoenix Rehabilitation and Health Services Inc (2,800 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 579
- Services billed
- 2,250
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 380 | 287 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 198 | 39 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 155 | 58 |
| Established patient office or other outpatient visit, 40-54 minutes | 152 | 139 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 96 | 30 |
| Established patient office or other outpatient visit, 20-29 minutes | 91 | 82 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | 77 | 60 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 62 | 27 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 43 | 19 |
| Injection of chemical for paralysis of nerve muscles on side of face | 38 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Philadelphia, PA | 871 |
| Clonazepam Other prescribers in Philadelphia, PA | 204 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Philadelphia, PA | 196 |
| Amantadine (amantadine hcl) Other prescribers in Philadelphia, PA | 181 |
| Rasagiline Mesylate | 145 |
| Donepezil Hcl Other prescribers in Philadelphia, PA | 116 |
| Rytary (carbidopa/levodopa) Other prescribers in Philadelphia, PA | 104 |
| Nuplazid (pimavanserin tartrate) | 88 |
| Entacapone | 85 |
| Gabapentin Other prescribers in Philadelphia, PA | 83 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 7 payments worth $1,592 in total to this clinician.
| Boston Scientific Corporation | $1,304 |
|---|---|
| Insightec,inc | $146 |
| Abbott Laboratories | $142 |
| Consulting Fee | $1,000 |
|---|---|
| Food and Beverage | $592 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Jan 16, 2025 | Consulting Fee General - DBS · General - DBS_NMD | $1,000 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $12,353 in research payments for these studies, mostly to the institutions running them.
- An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease
UCB SA · Terminated · NCT05543252 - Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease
AbbVie Inc. · Completed · NCT04750226 - M20-098 - Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson Disease
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.